Boehringer Ingelheim is a corporate venture arm. Based in Ingelheim am Rhein, Rhineland-Palatinate, Germany. Known portfolio companies include Otto, Ilara Health, Promethera Biosciences, Click Therapeutics, MabVax Therapeutics and NBE-Therapeutics, 9 companies in all.
Is Boehringer Ingelheim a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Who to pitch at Boehringer Ingelheim
Boehringer Ingelheim portfolio companies (9)
- Otto
- Ilara Health
- Promethera Biosciences
- Click Therapeutics
- MabVax Therapeutics
- NBE-Therapeutics
- Yale Cancer Center
- Greybox Solutions
- Proxygen
Co-investors
Funds that share portfolio companies with Boehringer Ingelheim.
Similar funds
Showing 20 of 100
About Boehringer Ingelheim
The firm's listing covers sectors AI and Healthcare, and focus areas AI Applications, Animal Health, Biotech and Digital Health; known deals cluster at Growth, Late-Stage and Series A.
The team counts 11 people in our database. Bijon Duran (Group Leader), Sebastian Kreuz (Head of Boehringer Ingelheim Venture Fund EU) and Yifang Cui (Investment Director) are shown as the contacts to pitch.
Across the known portfolio, 18 co-investors appear alongside Boehringer Ingelheim, including Villgro Africa, Good & Well and BioMark Capital.
Frequently asked questions
What is Boehringer Ingelheim?
Boehringer Ingelheim is a corporate venture arm based in Ingelheim am Rhein, Rhineland-Palatinate, Germany, with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Boehringer Ingelheim invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Animal Health, Biotech and Digital Health. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Boehringer Ingelheim invest at?
The known deals of Boehringer Ingelheim include Growth, Late-Stage and Series A rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Boehringer Ingelheim?
3 of the 11 people on file at Boehringer Ingelheim are listed as contacts for the firm. All 11 have their own profile page.
How do I contact Boehringer Ingelheim?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 11 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal